Bath & Body Works, Inc. 8K

Bath & Body Works, Inc. reported Q2 2026 results that exceeded guidance and raised full-year 2026 EPS guidance while narrowing its sales outlook amid ongoing business transformation efforts.

Bath & Body Works, Inc. reported its second quarter 2026 financial results, announcing net sales of $1.514 billion (down 2.3% year over year) and earnings per diluted share of $0.58 (adjusted to $0.62 excluding $9 million of business transformation costs), with results exceeding prior guidance, aided by approximately $80 million of tariff refunds and the first growth in direct channel net sales since 2021; the company also updated its 2026 outlook by narrowing full-year net sales guidance to a decline of 4% to 2.5% versus 2025, raising full-year GAAP EPS guidance to $3.13–$3.33 and adjusted EPS guidance to $2.60–$2.80, and forecasting about $650 million of free cash flow while highlighting ongoing transformation initiatives under its Consumer First Formula strategy.

Filing Facts

CIK

701985

Ticker

-

Form

8K

Source Type

sec

Accession

0000701985-26-000025

Alert Tier

6